Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug
Eli Lilly's new weight loss drug, retatrutide, shows promising results in combating obesity. In a recent clinical trial, participants lost an average of 70.3 pounds, with many achieving significant weight loss. This development follows a trend initiated by earlier drugs like Ozempic and Wegovy, which have also contributed to changes in dietary habits among Americans.
- ▪Participants in the trial lost an average of 70.3 lbs over 80 weeks.
- ▪45.3% of participants achieved a weight loss of 30% or more.
- ▪The drug is part of a new wave of hormonal treatments for obesity and diabetes.
4 outlets in our directory ran this story, first to last over 33 hours. Coverage spans 2 points on the political spectrum — 2 lean left, 1 centre.
- ▪ Lilly’s new experimental shot produced 28% weight loss — MarketWatch — Top Stories
- ▪ Experimental Drug Yields Dramatic Weight Loss — NYT > Top Stories
- ▪ People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says — NBC News — Health
Reason Magazine files mainly under politics. We currently carry 506 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Reason.com |
| Canonical URL | https://reason.com/2026/05/22/is-the-end-of-the-obesity-epidemic-near-people-lost-up-to-85-pounds-using-new-weight-loss-drug/ |
| Publication time | Fri, 22 May 2026 19:30:13 +0000 |
| Retrieval time | 2026-05-22T19:42:02.745Z |
| Last seen | 2026-05-22T19:52:20.517Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 7hq_qh4jc-OV · 4 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Obesity Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy. Ronald Bailey | 5.22.2026 3:30 PM Share on FacebookShare on XShare on RedditShare by emailPrint friendly versionCopy page URL Add Reason to Google Media Contact & Reprint Requests <img src="https://d2eehagpk5cl65.cloudfront.net/img/c800x450-w800-q80/uploads/2026/05/obesity-decrease-v1-800x450.jpg" style="max-width: 100%; height: auto" width="1200" height="675" title="An illustration of a person standing on a scale" alt="An illustration of a person standing on a scale | Midjourney/Dragan Andrii/Dreamstime" /> (Midjourney/Dragan Andrii/Dreamstime) Rumors about the astonishing…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Reason.com.
Discussion
0 commentsMore from Reason.com
